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ABSTRACT 
STATISTICAL PARAMETRIC MAPPING ANALYSIS OF POSITRON EMISSION 
TOMOGRAPHY IMAGES FOR THE DETECTION OF SEIZURE FOCI: RESULTS IN 
TEMPORAL LOBE EPILEPSY. Jeffrey R. Tseng, Rajesh Krishnamurthy, Douglas 
Bremner, Susan S. Spencer, Dennis D. Spencer, Holley M. Dey. Section of Nuclear 
Medicine, Department of Diagnostic Radiology, Yale University, School of Medicine, New 
Haven, CT. 
The puipose of this study was to determine the efficacy of statistical parametric 
mapping (SPM) of [18F]-fluoro-2-deoxyglucose (FDG) positron emission tomography 
(PET) images of the brain for the localization of seizure foci in patients with temporal lobe 
epilepsy (TLE). 
Preoperative PET brain scans from 36 patients with TLE and from 8 healthy control 
subjects were retrospectively analyzed with SPM95 software written for Matlab version 
4.2. Scans were transformed to Talairach space, globally normalized, and smoothed. 
Differences between each patient’s scan and the control group were then computed with the 
t statistic on a voxel by voxel basis. SPM maps were thresholded at p < 0.001 and 
reviewed for areas of significant hypometabolism relative to the control group. All 44 
clinical 18FDG brain scans were also visually interpreted and regions of metabolic 
asymmetry noted. Localization of the seizure focus by both SPM and visual analyses were 
compared with each patient’s temporal lobe resection site and with that patient’s post- 
surgical outcome. A good post-surgical outcome was defined as > 90% reduction in seizure 
frequency six months after operation. 
SPM analysis predicted the surgical excision site in 32/36 patients (89%); visual 
analysis also correctly lateralized the temporal lobe resection site for 32/36 patients (89%). 
The SPM and visual analyses were concordant in 30/36 (83%) cases; both provided a false 
negative result in one cases. Of the 36 TLE patients, 31 had a successful surgical outcome 
with > 90% reduction in seizure frequency six months after surgery. SPM analysis 
identified the temporal lobe seizure focus in 28/31 of these patients (90%). Visual analysis 

identified 29/31 (94%). Of the 5 patients with poor surgical outcome, SPM analysis 
showed significant contralateral frontotemporal hypometabolism in 3 cases, and contra¬ 
lateral perihippocampal localization in 2 cases. 
We conclude that SPM analysis of 18FDG PET images is useful for the localization 
of temporal lobe seizure foci in clinical and research settings. SPM provides a more 
objective and consistent means of image analysis for the evaluation of patients with 
epilepsy, particularly for inexperienced observers. Our data suggests that SPM analysis 
may also prove useful for the prediction of clinical outcome after temporal lobe resection. 
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INTRODUCTION 
Background - Clinical Epilepsy 
Epilepsy is a term used to describe a diverse collection of disorders that affects 
more than one percent of the population of the United States (1). These disorders are 
characterized by episodic abnormal, paroxysmal electrical discharges within the brain that 
are manifested as recurrent, spontaneous seizures (2). Seizures that begin within a localized 
region of the brain cortex are termed “partial”. Generalized seizures diffusely involve both 
cerebral hemispheres at the onset. 
While a simple partial seizure does not impair the level of consciousness, a complex 
partial seizure is associated with loss of contact (1). This impairment of consciousness can 
be disabling for patients who suffer from recurrent and unpredictable complex partial 
seizures, and can lead to poor school/work performance, and eventually an inability to 
function independently (3). For some patients, medical treatment may be sufficient to 
control seizure activity. However, many patients have intractable complex partial epilepsy 
that cannot be controlled with reasonable doses of medication at tolerable levels of side 
effects. These patients may benefit from surgical excision of the epileptogenic focus in the 
brain, if this focus can be well localized. 
Medically refractory patients comprise approximately 10-20% of the more than two 
million people in this country with epilepsy (4). Of these, up to 50% have complex partial 
seizures that are potentially localizable, and therefore amenable to surgical therapy. The 
majority of complex partial seizures appear to arise from the temporal lobe (1). Following 
temporal lobe surgery approximately 50-70% of patients with complex partial seizures 
become seizure free, 10-30% are significantly improved, and the remaining 15-30% show 
little or no improvement (5,6). 
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Localization of Epileptic Foci 
Selection of a patient with complex partial epilepsy for surgical therapy requires that 
the abnormal electrical discharges within the brain be clearly and consistently localized to a 
specific brain region. The presurgical evaluation of patients who are considered for 
epilepsy surgery is completed in stages. During the first stage, non-invasive testing is 
performed to screen patients and to plan additional testing for those patients who may be 
surgical candidates. During the second and third stages, progressively more invasive 
testing is performed for those patients whose Stage 1 localization is ambiguous. This 
invasive testing includes intracranial electroencephalographic (EEG) monitoring (7). 
The Stage 1 evaluation includes a thorough medical history and physical 
examination, neuropsychological testing, ictal and interictal scalp EEG recordings, and a 
series of imaging studies. The medical history may describe clinical features of the patient’s 
epilepsy that are consistent with lateralization or localization of the seizure focus. The 
neuropsychological tests are used to identify areas of intact and/or impaired cognitive 
function that may be associated with an identified epilepsy syndrome (7). 
Scalp ictal and interictal EEG recordings have classically been the mainstay of 
seizure diagnosis and localization. The first epilepsy surgeries relied primarily on interictal 
EEG identification of the seizure site. While the interictal scalp EEG remains an important 
part of the diagnostic work-up of patients with epilepsy, the technique can reveal 
ambiguous patterns and incorrect localization. Seizure foci may also remain undetected 
(8,9). Video EEG recordings permit correlation of the patient’s ictal EEG pattern with 
clinical behavior. This data can enhance the probability of accurately localizing the seizure 
focus. However, the ictal EEG may falsely lateralize the seizure focus due to 
muscle/movement artifact, rapid spread of abnormal electrical activity to bilateral or remote 
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brain areas, or seizure onset in a deep brain region (7). In these cases, non-invasive 
imaging studies may provide critical localizing information. 
Radiographic and nuclear medicine studies can detect structural and functional 
abnormalities in the brain that are correlated with epileptic seizure foci (2). Structural 
imaging includes computed tomography (CT) and magnetic resonance imaging (MRI); 
functional imaging includes single photon emission computed tomography (SPECT) and 
positron emission tomography (PET). MRI and CT can identify small structural lesions 
such as hamartomas, gliomas, and vascular malformations that may be the cause of seizure 
activity. MRI may also define structural abnormalities within the temporal lobe and/or 
hippocampus in patients with probable temporal lobe epilepsy. SPECT can detect regional 
hypoperfusion in patients with lateralized epilepsy, with a sensitivity of 66% for temporal 
and 60% for extratemporal lobe epilepsy. PET is used to identify focal hypometabolism in 
the region of the seizure focus; a sensitivity of 84% has been reported for temporal lobe 
epilepsy, 33% for extratemporal lobe epilepsy. Where available, interictal PET is preferred 
for functional imaging of the patient with suspected temporal lobe epilepsy. 
Stage 1 evaluation of the patient with potentially localizable epilepsy now includes a 
conglomeration of clinical, EEG, and imaging tests. When the summed data, including 
surface EEG and imaging tests, provide a concordant seizure site localization, some 
epilepsy surgery centers now proceed directly to surgical resection, circumventing the need 
for more invasive intracranial EEG recording with its attendant surgical risks of cerebral 
infection and hemorrhage (10-12). 
Positron Emission Tomography 
PET imaging uses very small amounts of positron emitting radiopharmaceuticals to 
identify and measure tissue function. Short-lived radioactive isotopes of elements such as 
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carbon, oxygen, nitrogen, and fluorine are chemically “tagged” to compounds of 
physiologic importance; these radiopharmaceuticals are then internally administered to the 
patient. Organ specific uptake of the radiopharmaceutical is based upon the chemical 
structure of the injected compound. For example, [1 ICjacetate, a marker of myocardial 
oxidative metabolism, is targeted for and avidly extracted by heart muscle. A specialized 
PET camera is then used to detect and record the annihilation photons that result when the 
administered positrons interact with tissue electrons in the organ of interest (13,14). Images 
of the distribution of the positron emitting radiopharmaceutical within tissue are generated 
through a complex mathematical process known as filtered back projection. The resulting 
image is a cross-section of the tissue or organ, with the intensity of each pixel element 
proportional to the concentration of the radiopharmaceutical at that position in the body. 
Patients with epilepsy have been successfully imaged with the PET 
radiopharmaceutical [18F]fluoro-2-deoxyglucose (FDG), an analog of glucose (15). FDG, 
like glucose, is actively extracted into brain tissue, and is phosphorylated by hexokinase in 
the first step of the glycolytic pathway. Unlike glucose, FDG is not further metabolized and 
is essentially trapped in tissue. Images of FDG distribution within the brain therefore reflect 
regional cerebral glucose utilization, with the highest concentrations of radiopharmaceutical 
found in areas of greatest metabolic activity. 
PET images reveal reduced interictal cerebral glucose metabolism in patients with 
epilepsy (15-18). This evidence is particularly strong for patients with complex partial 
seizures of temporal lobe origin. A recent retrospective review of the literature showed that 
asymmetrically decreased metabolic activity within the temporal lobe accurately localizes the 
seizure focus in patients with complex partial epilepsy. The sensitivity of FDG PET for 
temporal lobe epilepsy as compared to an EEG gold standard was 84%, with a specificity 
of 86% (1). 
Compared to a tissue pathology gold standard, the sensitivity of PET for temporal 

5 
lobe epilepsy was 81%, with a specificity of only 22%. This lower specificity may 
represent extension of PET hypometabolism beyond the pathology defined seizure site, 
consistent with a larger area of functional disturbance within the brain than would be 
expected on the basis of structural changes alone. Analysis of the distribution of 
radiolabeled FDG within the temporal lobe has had varying results; recently, Hajek etal 
related tissue pathology to FDG distribution within the temporal lobe (1). Patients with 
medial temporal lobe epilepsy showed diffuse temporal lobe hypometabolism; patients with 
temporal neocortical epilepsy had more limited hypometabolism within the lateral temporal 
cortex. 
Several studies have related PET findings to surgical outcome in epilepsy. PET 
hypometabolism predicts a favorable clinical outcome for 71-96% of patients (20-23). It 
should be noted, however, that published studies lack consistency in the method of PET 
data analysis and in the definition of a “good” surgical outcome after epilepsy surgery. 
Table 1 summarizes these studies. 
PET Image Analysis 
PET image analysis can be performed by qualitative or quantitative means. 
Qualitative analysis consists of the identification of regions of hypometabolism through 
visual interpretation. In patients with suspected temporal lobe epilepsy, FDG PET images 
of the temporal lobes are carefully examined for global and/or regional asymmetries in 
radiopharmaceutical uptake. Left is compared to right in order to detect areas of 
abnormality. A rough measure of the severity of hypometabolism can be made by judging 
the degree of asymmetry between the abnormal temporal lobe and the presumably normal 
contralateral side. 
Visual qualitative analysis is necessarily subjective and requires the observer to 
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Studv 
No. of 
Patients 
No. of 
Good 
Outcome 
No. of 
Poor 
Outcome Definition of Good Surgical Outcome 
Heinz et al (20) 24 17 (71%) 7 (29%) > 90% reduction, < 10 seizures/year 
Manno et al (21) 35 29 (83%) 6(17%) seizure free 
Radtke et al (22) 25 24 (96%) 1 (4%) > 75% reduction of seizures 
Theodore et al (23) 42 35 (83%) 7(27%) seizure free 
Table 1 Summary of studies comparing PET imaging with surgical outcome for patients 
with temporal lobe hypometabolism and subsequent temporal lobectomy. 
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pinpoint differences in image intensity in order to identify a region of abnormality. The 
observer is also asked to relate areas of abnormality to regional brain anatomy. These tasks 
may prove difficult for an inexperienced reader (24). Qualitative interpretation of FDG PET 
can also be complicated by a bilateral temporal or diffuse reduction in metabolism that 
precludes identification of a metabolic asymmetry. For example, global hypometabolism 
that results from use of antiepileptic drugs (AED) may mask localized epileptic foci (25). 
PET images of regional cerebral glucose metabolism can also be quantified. 
Quantification can lend objectivity to image analysis that is not possible through visual 
interpretation. Quantification requires a computer based region of interest analysis to 
determine the concentration of radioactivity within user defined regions of interest in the 
temporal lobe and whole brain. Radioactivity concentration can be described as: 1) an 
absolute measurement, with the local cerebral glucose metabolic rate given in units of 
mg/100 gm/min ; 2) a ratio of activity in the region of interest to activity in a normal area of 
metabolism. The “normal” area might be the homologous contralateral brain cortex, or an 
area such as the cerebellum that is presumably unaffected by the temporal lobe epilepsy 
process. 
Absolute quantification of the cerebral glucose metabolic rate can be performed 
using a model developed by Sokoloff et al and is based upon knowledge of the arterial 
input function into the brain and plasma glucose concentration (26). Calculation of an 
absolute metabolic rate therefore requires serial blood samples from the patient to determine 
the amount and time course of delivery of injected radiopharmaceutical to the brain, as well 
as the plasma glucose concentration. Problems with absolute value analysis are the 
necessary complexity of the analysis, the requirement for frequent invasive blood draws, 
and possible confounding of the results by AED use (27,28). Quantitative analysis is also 
plagued by compromises between sensitivity and specificity when determining appropriate 
threshold values for normality (21,29). In addition, semi-quantitative ratio analysis is 
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problematic since bilateral and/or global hypometabolism can deter attempts to identify a 
localized focus of abnormality. 
The purpose of this research project was to evaluate the utility of a new tool, 
statistical parametric mapping analysis (SPM) of FDG PET, for the detection of seizure foci 
in patients with complex partial epilepsy. SPM refers to the construction of statistical maps 
of change significance, in which the patient’s images of cerebral glucose metabolism are 
compared on a voxel by voxel basis to images from a group of healthy controls such that 
areas of significant difference are highlighted. SPM has several theoretical advantages over 
current methods for FDG PET brain image analysis. These include substantial elimination 
of subjectivity in image analysis, more precise anatomic localization of functional 
abnormalities, and avoidance of blood sampling. Additionally, bilateral and global changes 
in metabolism are not masked as each patient can be compared to a normal healthy control 
population. 
Statistical Parametric Mapping 
Statistical parametric mapping (SPM) has been used to evaluate PET images of 
regional cerebral blood flow and metabolism and to identify significant changes from the 
patient’s own baseline or from healthy control subjects (30-32). Applications for SPM have 
been reported in PET studies of memory, sensory and motor activation, Alzheimer's 
disease, Parkinson's disease, and amyotrophic lateral sclerosis (33-37). Based on these 
reports, we believed that SPM analysis would prove useful for the detection of abnormal 
temporal lobe metabolism. 
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STATEMENT OF PURPOSE 
The primary objective of this study was to compare the utility of statistical 
parametric mapping (SPM) analysis to visual interpretation of FDG PET brain images for 
the detection of seizure foci in patients with complex partial epilepsy. A secondary objective 
was to determine the relationship between the SPM defined seizure focus and clinical 
seizure outcome following epilepsy surgery. 
We hypothesized that SPM analysis would prove more sensitive than visual 
analysis for the detection of seizure foci and for the prediction of post-operative seizure 
outcome in patients with complex partial epilepsy, based on the greater objectivity and 
greater potential sensitivity of the statistical method. 
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METHODS 
Patient Selection 
From January 1992 to June 1996, 156 patients with complex partial seizures of 
presumed temporal lobe origin were referred to the Yale-VA PET Center for imaging of 
regional cerebral glucose metabolism. Of this number, 80 patients subsequently underwent 
temporal lobectomy and had at least six months of clinical follow-up data available at the 
time of this study. From this group of subjects, 28 patients with known neoplastic or 
vascular lesions within the temporal lobe as identified from pathology, biopsy, or MRI 
reports were excluded. Image data could be retrieved for 36 of the remaining 52 patients. 
These 36 PET image data sets were retrospectively reanalyzed, and the results compared 
with each patient’s surgical resection site and post-surgical outcome. 
There were 18 men and 18 women in the group of epilepsy patients. Mean patient 
age at the time of PET imaging was 35.1 yrs. (range 9.2 - 55.3 yrs.). The mean duration of 
illness was 28.7 yrs. (range 4.2 - 51.0 yrs.). Average age of seizure onset was 6.4 yrs. 
(range 0-36 yrs.). 
Image data from 8 healthy control subjects were also retrospectively reviewed and 
reanalyzed. The healthy control subjects were eight men with a mean age of 44 (range 25 - 
60). Healthy subjects had no history of significant medical disease, and specifically no 
neurologic or psychiatric complaints. Each control subject provided a complete medical 
history, underwent a physical examination, and had normal serum chemistry and 
hematology tests prior to inclusion in the normal database. These patient studies were 
approved by the V.A. Institutional Review Board protocol under the direction of Dr. 
Douglas Bremner. 
Presurgical evaluation for all epilepsy patients included ictal and interictal surface 
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EEG and PET scan. In addition, intracranial EEG, MRI, ictal and interictal SPECT, 
neuropsychiatric testing, and cerebral angiography may have been performed during the 
course of the staged pre-surgical evaluation. 
All 36 epilepsy patients underwent temporal lobectomy. The standard surgery was 
an anteromedial temporal lobectomy with hippocampectomy. The extent of tissue resection 
differed between patients, and was based on the results of pre-surgical testing. There were 
a total of 24 left sided resections and 12 right sided. 
PET Imaging 
PET studies were performed on a Posicam 6.5 whole body camera (Positron 
Corporation, Houston, Texas). Patients were positioned in the camera gantry with the 
orbital meatal line oriented to the x-y plane. An intravenous injection of 10 mCi of 18-FDG 
was then administered. During radiopharmaceutical injection the patient’s eyes remained 
open and the camera room was dimly lit. Extraneous noise was minimized, and soft 
background music was played during and after dose administration. Forty-five minutes 
were allowed for clearance of FDG from the blood pool and uptake into brain. Image data 
were subsequently acquired until approximately 60 million positron annihilation events 
were recorded (approximately 20 min.). Two overlapping brain scans were obtained for 
each patient in order to maximize the likelihood of obtaining high quality images of the 
temporal lobes. 
The axial field of view of the camera was 11.5 cm. Twenty-one image slices were 
acquired, separated by 5.125 mm with an axial resolution of 11 mm. In plane resolution 
was 5.7 mm (full width at half maximum). A theoretical attenuation correction was applied 
to the acquired image data; a uniform attenuation coefficient of 0.096 cm'1 was applied. 
Transverse image reconstruction was performed using filtered backprojection with a 
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Butterworth 8 filter using a cutoff of 0.04, cutoff fraction of 0.306, and filter order of 
10.0. Images were reconstructed in a 256 x 256 matrix with a pixel size of 1.7 mm. 
Reoriented tomograms were displayed in the axial, coronal, and sagittal planes. A graded 
color display was normalized to the area of maximum activity. Each change (gradation) in 
color represented a 5% difference in normalized intensity. 
PET Visual Analysis 
PET brain images were visually interpreted by an experienced nuclear medicine 
physician (H.M.D.) who was blinded to the patients’ clinical information, except the 
knowledge that patients had a surgical epilepsy procedure. Visual analysis involved careful 
review of each patient’s PET scan with comparison of relative FDG uptake within 
homologous brain regions utilizing the graded color display. Areas of relative 
hypometabolism were recorded on data sheets (see Appendix). For each abnormal region 
the affected lobe/structure (temporal, frontal, parietal, occipital, cerebellum, thalamus, basal 
ganglia) was noted, and the distribution of hypometabolism within that region (medial 
/lateral, anterior/posterior, and superior/inferior) was defined. An asymmetry index was 
generated for each abnormal brain region by comparing FDG uptake within the 
hypometabolic lobe to uptake within the contralateral homologous brain tissue. The 
asymmetry index was based upon the graded color image display scale. Differences in 
uptake between the temporal lobes, for example, was recorded as: None (< 5% asymmetry 
in uptake on the graded color scale). Minimal (5-10% asymmetry). Mild (10-15% 
asymmetry), Moderate (15-20% asymmetry), or Severe (>20% asymmetry). When both 
homologous brain regions appeared hypometabolic, an additional measure of uptake, 
termed the “absolute index”, was generated by comparing activity within the regions of 
abnormality to uptake within a presumably normal area of brain metabolism (typically the 
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cerebellum). For each patient’s PET scan an overall reading was generated, with the area of 
most significant hypometabolism defined as the likely seizure site. 
PET SPM Analysis 
Image data from all 36 patients with temporal lobe epilepsy and from the 8 healthy 
control subjects were transferred to a SUN SPARC station 10 for SPM analysis. The 
image data were analyzed using SPM95 software written for Matlab version 4.2. 
Preprocessing of the data prior to statistical analysis was required. All scans were 
transformed into Talairach space based on an automated computer definition of the anterior- 
posterior commissural line. This procedure ensured that functional brain abnormalities 
could consistently be mapped to brain anatomy using the Talairach stereotaxic brain atlas. 
Data sets were then globally normalized to correct for individual differences in the injected 
dose of radioactivity, and smoothed. A statistical analysis of the data sets was performed. 
Each patient’s PET scan was compared against data sets from the 8 healthy control subjects 
on a voxel by voxel basis with computation of the t statistic. A statistical map representing 
change significance between the patient’s PET scan and the normal database was generated 
and thresholded at p < 0.001. Voxels with z scores > 3.0 (p < 0.001) were highlighted on 
coronal, axial, and sagittal image displays. An experienced nuclear medicine physician 
(H.M.D.) then visually analyzed the SPM maps to describe areas of regional 
hypometabolism. The likely seizure site was defined as that localized brain region 
demonstrating the most significant hypometabolism on SPM map. Where present, 
extension of hypometabolism to include remote areas of brain cortex was described in the 
SPM interpretation. 
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Statistical Analysis for Localization and Surgical Outcome 
Both the visual and SPM analyses of the PET data were retrospectively compared to 
each patient’s chosen surgical site. The sensitivity of both visual and SPM analyses for 
localization of the seizure site as defined by the surgery gold standard was calculated. The 
PET analyses were considered to have provided a true positive localization if the major 
identified focus of hypometabolism matched the surgical site, regardless of the presence of 
additional, less significant areas of hypometabolism. When homologous brain regions were 
bilaterally abnormal, the more hypometabolic side was labeled as the likely seizure focus. 
Both visual and SPM PET data analyses were also compared with the patients’ 
post-surgical outcome data. For this purpose, a good surgical outcome was defined as a 
greater than 90% reduction in seizure frequency 6 months after operation. Thirty-two of the 
36 patients were evaluated at > 1 year after surgery. A poor surgical outcome was 
considered less than a 90% reduction in seizure activity. For both visual PET interpretation 
and SPM analysis positive predictive values were calculated. The sensitivities and positive 
predictive values of the PET analyses for surgical outcome were compared using the 
McNemar test. 
Pathology Analysis 
For 33/36 epilepsy patients the results of histopathologic examination of the 
resected brain tissue were available. Abnormal findings within the resected temporal lobe 
were recorded and variably classified as hippocampal sclerosis, non-hippocampal gliosis, 
congenital abnormality (e.g. heterotopia), or other. Histopathology findings were then 
compared with the regional cerebral distribution of hypometabolism defined by visual and 
statistical analyses of the PET image data. 
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RESULTS 
PET Imaging Results 
Results of the visual analysis of the FDG PET scans are provided in Table 2. 
Temporal lobe hypometabolism was identified in 33 of 36 patients. One patient had 
regional hypometabolism limited to the frontal lobe. Two patients had PET scans that were 
interpreted as showing no focal abnormality. Relative temporal hypometabolism was 
visually graded as follows: a severe asymmetry was found in 12 cases, moderate 
asymmetry in 8, mild asymmetry in 11, and minimal in 2 cases. Extratemporal ipsilateral 
extension of hypometabolism was identified in 21 patients for a total of 29 extratemporal 
sites. Extratemporal hypometabolism was described as follows: a frontal lobe abnormality 
was found in 13 patients, parietal lobe in 8, occipital lobe in 5, thalamic hypometabolism 
was noted in 1, basal ganglia abnormality in 2 cases. Bilateral temporal lobe 
hypometabolism was present in 5 patients. 
Table 2 describes the results of the SPM analysis of the FDG PET data. Temporal 
lobe hypometabolism was present in 35/36 patients. Of these, 21 regions of 
hypometabolism were classified as frontotemporal and 3 as temporooccipital. One patient 
had a discrete occipital lobe abnormality. There were no normal scans. Bilateral extension 
of hypometabolism was found in 29 patients. Visual analysis of the SPM maps graded the 
extratemporal extension of hypometabolism as follows: severe extension in 8 cases, 
moderate in 6, mild in 7, and minimal in 7 cases. The location of the extensions were as 
follows: frontotemporal in 20 cases, frontal in 4, temporal in 3, and temporooccipital in 2 
cases. 
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Visual Analysis SPM Analysis 
Surgical 
Outcome 
Surgical 
Site Side Location Major Reqion Bilateral Extension 
Pt. 
No. 
Good Left - normal L frontotemp severe R frontotemp/perihipp 1 
Good Left B (L>R) temp L temp mild R front 2 
Good Left B (L>R) temp + front L frontotemp mild R frontotemp 3 
Good Left B (L>R) temp + front L frontotemp severe R frontotemp 4 
Good Left Left temp L frontotemp min R front 5 
Good Left Left temp L frontotemp min R frontotemp 6 
Good Left Left temp L frontotemp mod R frontotemp 7 
Good Left Left temp L frontotemp mod R frontotemp/perihipp 8 
Good 
Good 
Left Left temp L frontotemp none 9 
Left Left temp L frontotemp severe R frontotemp 1 0 
Good Left Left temp L temp none 1 1 
Good Left Left temp + front L frontotemp mild R temp 1 2 
Good Left Left temp + front L frontotemp mod R frontotemp 13 
Good Left Left temp + front L frontotemp none 14 
Good Left Left temp + front L frontotemp severe R frontotemp/perihipp 1 5 
Good Left Left temp + front + parietal L temp min R front 16 
Good Left Left temp + occip + BG L temporooccip min R frontotemp 1 7 
Good Left Left temp + parietal L frontotemp min R front 18 
Good Left Left temp + parietal L temp none 1 9 
Good Left Left temp + parietal + occip L frontotemp mod R temp 20 
Good Left Left temp + parietal + occip + front L temp min R frontotemp 21 
Good Right B (L>R) temp + front + thalamus L temp mild R frontotemp 22 
Good Right Right temp R frontotemp severe L frontotemp 23 
Good Right Right temp R temp none 24 
Good Right Right temp R temp none 25 
Good Right Right temp + front L frontotemp mild R frontotemp 26 
Good Right Right temp + front L occip none 27 
Good Riqht Right temp + front + occip R frontotemp mod L frontotemp 28 
Good Riqht Right temp + front + parietal R temporooccip mod L tempoccip 29 
Good Riqht Right temp + parietal L temp severe R frontotemp 30 
Good Riqht Right temp + parietal R temp min L frontotemp 31 
Poor Left B (L>R) temp L temp mild R temp/perihipp 32 
Poor Left Left frontal + BG L frontotemp mild R frontotemp/perihipp 33 
Poor Left Left temp L frontotemp severe R frontotemp 34 
Poor Right - normal R temporooccip severe L tempoccip 35 
Poor Riqht Riqht temp + occip R frontotemp severe L frontotemp 36 
Table 2. Results of surgical site, surgical outcome, visual PET analysis, and SPM PET 
analysis. For surgical outcome, "good" represents > 90% seizure reduction at a 
minimum of 6 months follow-up; "poor" represents < 90% seizure reduction. 
Surgical site lists the side of the temporal lobectomy. Visual analysis lists side 
and location of hypometabolism. SPM Analysis lists side and location of the 
major region of hypometabolism along with significant bilateral extensions and 
degree. PET analyses which do not agree with surgical site are highlighted. 
Abbreviations: B = bilateral; L = left; R = right; temp = temporal lobe; parietal = 
parietal lobe; occip = occipital lobe; front = frontal lobe; min = minimal; mod = 
moderate; perihipp = perihippocampal region. 
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Localization of Epileptic Foci Analysis 
Visual analysis was concordant with the surgical site in 32/36 (89%) cases. Two 
scans were normal (Patients 1 and 35). One patient was incorrectly lateralized (Patient 22). 
One patient was localized to the wrong lobe of the brain (Patient 33). 
SPM analysis was also concordant with the surgical site in 32/36 (89%) cases. 
Four patients were incorrectly lateralized (Patients 22, 26, 27, 33). Patient 33 was 
incorrectly lateralized by both visual and SPM analyses. The SPM and visual analyses were 
concordant in 30/36 (83%). There was no difference between the sensitivities of visual vs. 
SPM analyses for detection of the temporal lobe resection site. 
Surgical Outcome Analysis 
Favorable clinical outcomes were reported for 31 of 36 (86%) patients. Visual 
analysis identified 29/31 (94%), while SPM analysis identified 28/31 (90%) cases. Figures 
1 and 2 show clinical PET and SPM image data from Patient 16 with a good surgical 
outcome. There was no statistically significant difference between the positive predictive 
values of PET visual and SPM analyses for favorable post-surgical outcome. 
Five patients had poor surgical outcomes, with frequent recurrent seizures. One of 
these patients had bilateral temporal lobe hypometabolism by visual analysis. SPM revealed 
severe contralateral temporal hypometabolism in 3 cases (e.g. Patient 34 in Figure 3) and 
contralateral perihippocampal hypometabolism in 2 cases (e.g. Patient 32 in Figure 4). 
Of the five patients considered to have bilateral temporal hypometabolism on visual 
analysis, one had a poor clinical outcome. Of the 29 patients with bilateral temporal 
abnormalities on SPM analysis, 5 had a poor outcome. Of patients with severe bilateral 
extension of hypometabolism on SPM, 3/9 showed no improvement after epilepsy surgery. 
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Figure 1. PET image for visual analysis from Patient 16 with a good surgical outcome. 
Two coronal slices (A, B) and two transaxial slices (C, D) are shown. Left 
temporal lobe hypometabolism is evident in B and D. There is also frontal (A) 
and parietal (C) hypometabolism. 
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Figure 2. PET image for SPM analysis from Patient 16 with a good surgical outcome. The 
surgery was located on the left side, and the pathology report revealed 
hippocampal sclerosis. Sagittal, coronal, and transaxial views are shown. On the 
coronal view, the left side of the patient is displayed on the left side of the image. 
Left frontotemporal hypometabolism is present with a pixel size of 6693 and a Z- 
score of 5.06. 

16c 
Figure 3. PET image for SPM analysis from Patient 34 with a poor surgical outcome. The 
surgery was located on the left side, and the pathology report revealed 
hippocampal sclerosis. Sagittal, coronal, and transaxial views are shown. On the 
coronal view, the left side of the patient is displayed on the left side of the image. 
Bilateral (left > right) frontotemporal is present with a pixel size of 3305 and a Z- 
score of 4.87. 
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Figure 4. PET image for SPM analysis from Patient 32 with a poor surgical outcome. The 
surgery was located on the left side, and the pathology report revealed 
hippocampal sclerosis and non-hippocampal gliosis. Sagittal, coronal, and 
transaxial views are shown. On the coronal view, the left side of the patient is 
displayed on the left side of the image. Left frontotemporal hypometabolism is 
present with a pixel size of 6693 and a Z-score of 5.06. Contralateral right 
perihippocampal hypometabolism is also present with a pixel size of 140 and a 
Z-score of 4.36. 
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Pathology and Temporal Lobe Hypometabolism 
Histopathologic correlation was available for 33 patients. Results are summarized in 
Table 3. Microscopic examination of resected temporal lobe tissue revealed the following: 
hippocampal sclerosis in 18 patients, hippocampal sclerosis and non-hippocampal gliosis in 
7 cases, non-hippocampal gliosis in 5 cases, hippocampal sclerosis and heterotopia in 1 
case, hippocampal hemorrhage in 1 case, and heterotopia in 1 case. 
Visual PET image analysis revealed that 23/25 (92%) patients with hippocampal 
sclerosis or hippocampal sclerosis and non-hippocampal gliosis demonstrated ipsilateral 
temporal lobe hypometabolism that included the medial, anterior, and inferior regions. One 
scan was normal. One scan contained a defect in the frontal lobe. More detailed regional 
analysis showed medial > lateral hypometabolism in 20/25, anterior > posterior in 22/25, 
inferior > superior in 23/25 patients. Ipsilateral frontal extension of the hypometabolic zone 
was present in 8/25, parietal extension in 4/25, and occipital extension in 3/25. By SPM 
analysis, 24/25 cases had ipsilateral temporal lobe hypometabolism. 
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Regional Temporal Lobe Hypometabolism Pt. 
Patholoqy Medial vs. Lateral Anterior vs. Posterior Inferior vs. Superior No. 
hipp sclerosis medial>lateral anterior>posterior inferior>superior 1 8 
hipp sclerosis medial>lateral anterior>posterior inferior>superior 31 
hipp sclerosis medial>lateral anterior>posterior inferior>superior 2 
hipp sclerosis medial>lateral anterior=posterior inferior>superior 1 1 
hipp sclerosis medial>lateral anterior=posterior inferior>superior 9 
hipp sclerosis medial>lateral anterior inferior 4 
hipp sclerosis mediaklateral anterior>posterior inferior>superior 5 
hipp sclerosis mediaklateral anterior>posterior inferior>superior 20 
hipp sclerosis medialdateral anterior>posterior inferior>superior 7 
hipp sclerosis medialdateral anterior>posterior inferior>superior 12 
hipp sclerosis medialdateral anterior=posterior inferior>superior 34 
hipp sclerosis medialdateral anterior=posterior inferior>superior 1 6 
hipp sclerosis medialdateral anterior=posterior inferior=superior 1 3 
hipp sclerosis medialdateral anterior inferior>superior 1 5 
hipp sclerosis mediaklateral anterior>posterior inferior>superior 24 
hipp sclerosis medialdateral anterior=posterior inferior>superior 23 
hipp sclerosis mediaklateral anterior=posterior inferior>superior 1 4 
hipp sclerosis normal 1 
hipp sclerosis, qliosis mediaklateral anterior>posterior inferior>superior 32 
hipp sclerosis, qliosis mediaklateral anterior=posterior inferior>superior 1 7 
hipp sclerosis, qliosis mediaklateral anterior inferior>superior 22 
hipp sclerosis, qliosis mediaklateral anterior inferior 6 
hipp sclerosis, qliosis mediaklateral posterior inferior 28 
hipp sclerosis, qliosis medial anterior inferior 10 
hipp sclerosis, qliosis no temporal defect 33 
hipp sclerosis, heterotopia mediaklateral anterior> posterior inferior>superior 21 
gliosis mediaklateral anterior>posterior inferior>superior 25 
gliosis mediaklateral anterior>posterior inferior 26 
qliosis mediaklateral anterior=posterior inferior=superior 30 
gliosis mediaklateral anterior=posterior inferior=superior 29 
gliosis normal 35 
heterotopia lateral anterior=posterior inferior>superior 36 
none mediaklateral anterior>posterior inferior>superior 8 
none mediaklateral anterior inferior 27 
none mediaklateral anterior>posterior inferior>superior 3 
old hemorrhage in hipp mediaklateral anterior>posterior inferior>superior 1 9 
Table 3. Results of pathology and regional location of temporal lobe hypometabolism. 
Abbreviations: hipp = hippocampus; gliosis = non-hippocampal gliosis. 
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DISCUSSION 
SPM As a Useful Analytic Tool for Epilepsy 
PET images of regional cerebral metabolism have proven useful for the localization 
of seizure foci in patients with complex partial epilepsy. These images are most commonly 
interpreted through visual analysis. The reader is asked to compare homologous brain 
regions in order to identify areas of relative hypometabolism. The reader is then asked to 
map these functional abnormalities to specific anatomic structures/areas within the brain. 
These areas are then considered as potential sources for that patient’s seizure activity. Both 
tasks can be difficult for the inexperienced observer, leading to interpretive error. A more 
objective and consistent means of image analysis would be useful for the evaluation of 
patients with epilepsy. 
A number of quantitative/semi-quantitative methods for PET data analysis have 
been described. These include absolute quantification of regional cerebral glucose 
metabolism and ratio based region of interest analysis. Absolute quantification requires 
invasive blood sampling during acquisition of the PET data, as well as complex 
mathematical manipulation of the acquired data. Ratio based analyses are semi-quantitative 
and are not useful for the detection of bilateral or diffuse abnormalities. 
We have proposed using a new tool, statistical parametric mapping (SPM), for the 
objective analysis of FDG PET brain images in epilepsy. SPM is a powerful statistical 
method of localizing differences in regional cerebral metabolism. The patient’s image data 
are compared on a voxel by voxel basis to data from a group of normal, healthy control 
subjects using the Student’s t test. The results are displayed as a statistical map that 
represents images of change significance. These maps are thresholded such that voxels 
reaching a specified level of significance are highlighted. The theoretical advantages of 
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SPM include its objectivity, precise anatomic localization of functional abnormalities, 
avoidance of blood sampling, and the ready identification of diffuse and bilateral 
abnormalities. 
In this paper, we compared SPM to visual analysis of PET brain scans for the 
detection of seizure foci and prediction of post-surgical outcome in complex partial 
epilepsy. We found that SPM analysis identified the seizure focus, as defined by the 
eventual surgical resection site, in 32/36 (89%) patients that were evaluated. The SPM 
defined seizure site correlated with the surgical site in 28/31 (90%) patients who had good 
outcomes. These results are in agreement with the outcome of our own visual PET analysis 
and with published literature values that describe the utility of PET for seizure site 
identification (2,20-23). We conclude that SPM analysis is useful for the evaluation of PET 
data in epilepsy, and may provide an objective and sensitive means of seizure site 
identification. 
To the best of our knowledge, this is the first report of the use of SPM for FDG 
PET analysis in epilepsy. There has been one prior report, however, on the use of 
“statistical parametric imaging” (28). In this paper, the authors performed a statistical 
analysis that compared temporal lobe uptake of radiopharmaceutical to the patient’s own 
mean global cerebral metabolism. Image data from 17 patients were retrospectively 
reviewed by the authors; seizure foci for 16/17 patients were correctly lateralized using the 
statistical method. Unlike our study, patient data was not compared to a normal database of 
FDG images. Each patient served as his/her own control. It is therefore possible that 
regional hypometabolism was underestimated, and that areas of abnormality were not 
detected due to some level of global cerebral hypometabolism. Study of larger groups of 
patients would be necessary to determine whether our SPM method of data analysis is more 
sensitive than statistical parametric imaging for the detection of localized seizure foci. 
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Implications of Bilaterality and Extratemporal Extensions 
It is interesting to note that SPM analysis identified significant regions of 
hypometabolism both adjacent to and remote from the primary temporal focus of 
abnormality. When visual and SPM analyses were compared, it was clear that SPM more 
consistently identified extratemporal lobe extension of abnormal hypometabolism. This 
extended area most commonly involved the frontal lobe, but on occasion included the 
parietal or occipital cortex, and sometimes implicated the contralateral temporal lobe and 
hippocampus. 
Some published reports suggest that extratemporal lobe foci of hypometabolism 
connote a poor prognosis (22,38), while other reports show no discernable difference 
(23,39) in patient outcome. Our own results are preliminary, and not conclusive in this 
regard. We found that 29/36 patients had extratemporal lobe extension of hypometabolism 
on SPM analysis. This extratemporal extension was subjectively graded as “severe” in 9 
cases. When these 9 cases were reviewed, it was determined that 6 of the 31 patients with 
good post-surgical outcomes had diffuse hypometabolism on SPM analysis, while 3 of the 
5 patients with poor post-surgical outcomes had severe extratemporal extension of 
hypometabolism. Unfortunately, the number of patients with poor surgical outcome in our 
study, as well as in the other studies referenced above, is too small to draw any definite 
conclusions regarding a correlation between extratemporal lobe hypometabolism and 
prognosis in complex partial epilepsy. 
The pathophysiologic significance of extratemporal/bilateral hypometabolism on 
PET images of temporal lobe epilepsy is not clear. This scintigraphic finding may reflect 
deafferentation, with defective neuronal connections and projections between the 
hippocampus and temporal, extratemporal, and contralateral sites (40). These connections 
may be very fine; their detection might be facilitated by the use of SPM rather than the more 
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gross inspections made through visual analysis. Alternatively, extratemporal lobe 
hypometabolism may suggest a widespread ultrastructural brain abnormality that could 
have resulted from a congenital defect during critical periods of brain development (41). 
Comparison of Regional Temporal Hypometabolism to Histopathology 
Hippocampal sclerosis is a histopathologic diagnosis associated with temporal lobe 
epilepsy (41). Hippocampal sclerosis can be detected on MRI (42,43), and has been 
associated with PET temporal lobe hypometabolism (44). In our study, we subdivided the 
temporal lobe into medial, lateral, anterior, posterior, inferior, and superior regions during 
visual analysis. We found that 23/25 (92%) scans of patients with hippocampal sclerosis (± 
non-hippocampal gliosis) had inferior anteromedial temporal hypometabolism. This 
suggests that PET imaging may provide important non-invasive evidence for the presence 
of hippocampal sclerosis. 
Limitations of the Study 
This study was limited by the small size of the epilepsy patient, and especially of 
the healthy control, study groups. It is possible that comparison of patient data to a larger, 
more diverse population of healthy control subjects could reveal more limited areas of PET 
brain hypometabolism, and less extensive extratemporal extension of metabolic 
abnormality. 
This study was also limited by the absence of a literature based definition for the 
range of SPM significance. It is still unclear whether SPM readings should be based solely 
on z score, on the number of significant voxels, or on a combination of both criteria. In this 
study, the area of greatest z score significance was selected as the most likely seizure focus. 
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CONCLUSIONS 
In this study, SPM analysis of FDG PET brain images was as sensitive as visual 
analysis for the localization of seizure foci and for the prediction of favorable clinical 
outcome after epilepsy surgery. We would encourage the development of SPM as a 
supplement or alternative to visual analysis due to the ease of use and reproducibility of 
inteipretation. SPM is also useful for quantitative research analysis which can be compared 
to clinical data, imaging modalities such as SPECT and MRI, and pathology data such as 
hippocampal cell loss. 
SPM analysis revealed significant extension of PET hypometabolism to 
extratemporal brain regions. This finding may reflect the connections and projections of 
neurons from the hippocampus to other temporal lobe, extratemporal lobe, and contralateral 
sites. Alternatively, this widespread functional abnormality may result from developmental 
brain damage that includes extratemporal brain regions. 
Future directions for SPM would include creation of a large normal database of 
healthy subjects, and creation of more rigid interpretation criteria regarding the size and 
level of z score significance required to pinpoint the seizure focus. Continued investigation 
of the utility of SPM for the localization of both temporal lobe and extratemporal lobe 
epilepsies should be pursued. As more data is acquired, patterns may emerge that will 
enhance the likelihood of image based detection of epileptic foci. 
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APPENDIX 
PET - Epilepsy Data Form 
ID Label: 
Name: 
Date of PET: 
ID Number: 
Reader 1 = Dr. Holley Dey 
2 = Dr. Raiesh Krishnamurthv 
Overall 
Category 
1 = normal 
2 = temporal lobe only 
3 = temporal with frontal extension 
4 = temporal with parietal extension 
5 = temporal with occipital extension 
6 = temporal with other extension 
7 = frontal lobe only 
8 = frontal lobe with extension 
9 = parietal lobe only 
1 0 = parietal lobe with extension 
1 1 = occipital lobe only 
1 2 = occipital lobe with extension 
13 = other (describe below) 
Bilateral 1 = Yes 
Notes 
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REGION 1 REGION 2 
Lobe 1 = temporal 5 = cerebellar 
2 = frontal 6 = thalamus 
3 = parietal 7 = basal ganglia 
4 = occipital 
Lobe 1 = temporal 5 = cerebellar 
2 = frontal 6 = thalamus 
3 = parietal 7 = basal ganglia 
4 = occipital 
Area 1 1 = med. 2 = lat. 3 = med. + lat. Area 1 1 = med. 2 = lat. 3 = med. + lat. 
4 = med. > lat. 5 = lat. > med. 4 = med. > lat. 5 = lat. > med. 
Area 2 1 = ant. 2 = post. 3 = ant. +post. Area 2 1 = ant. 2 - post. 3 = ant. +post. 
4 = ant. > post. 5 = post. > ant. 4 = ant. > post. 5 = post. > ant. 
Area 3 1 = sup. 2 = inf. 3 = sup. + inf. Area 3 1 = sup. 2 = inf. 3 = sup. + inf. 
4 = sup. > inf. 5 = inf. > sup. 4 = sup. > inf. 5 = inf. > sup. 
Sp. Type 1 = focal 2 = diffuse/patchy Sp. Type 1 = focal 2 = diffuse/patchy 
Side 1 = left 2 = right Side 1 = left 2 = right 
3 = bilateral left = right 3 = bilateral left = right 
4 = bilateral left > right 4 = bilateral left > right 
5 = bilateral right > left 5 = bilateral right > left 
Metabol. 1 = hypomet. 2 = hypermet. Metabol. 1 = hypomet. 2 = hypermet. 
Asym. 1 Absolute 1 = < 5% (none) Asym. 1 Absolute 1 = < 5% (none) 
Index 2 Index 2 = 5-10% (minimal) Index 2 Index 2 = 5-10% (minimal) 
3 3 = 10-15% (mild) 3 3 = 10-15% (mild) 
4 4 = 15-20% (moderate) 4 4 = 15-20% (moderate) 
5 5 = > 20% (severe) 5 5 = > 20% (severe) 
6 6 = post op (missing) 6 6 = post op (missing) 
REGION 3 
Lobe 1 = temporal 5 = cerebellar 
2 = frontal 6 = thalamus 
3 = parietal 7 = basal ganglia 
4 = occipital 
Area 1 1 = med. 2 = lat. 3 = med. + lat. 
4 = med. > lat. 5 = lat. > med. 
Area 2 1 = ant. 2 = = post. 3 = ant. +post. 
4 = ant. > post. 5 = post. > ant. 
Area 3 1 = sup. 2 = inf. 3 = sup. + inf. 
4 = sup. > inf. 5 = inf. > sup. 
Sp. Type 1 = focal 2 = diffuse/patchy 
Side 1 = left 2 = right 
3 = bilateral left = right 
4 = bilateral left > right 
5 = bilateral right > left 
Metabol . 1 = hypomet. 2 = hypermet. 
Asym. 1 Absolute 1 = < 5% (none) 
Index 2 Index 2 = 5-10% (minimal) 
3 3 = 10-15% (mild) 
4 4 = 15-20% (moderate) 
5 5 = > 20% (severe) 
6 6 = post op (missing) 
REGION 4 
Lobe 1 = temporal 5 = cerebellar 
2 = frontal 6 = thalamus 
3 = parietal 7 = basal ganglia 
4 = occipital 
Area 1 1 = med. 2 = lat. 3 = med. + lat. 
4 = med. > la 5 = lat. > med. 
Area 2 1 = ant. 2 = post. 3 = ant. +post. 
4 = ant. > post. 5 = post. > ant. 
Area 3 1 = sup. 2 = inf. 3 = sup. + inf. 
4 = sup. > inf. 5 = inf. > sup. 
Sp. Type 1 = focal 2 = diffuse/patchy 
Side 1 = left 2 - right 
3 = bilateral left = right 
4 = bilateral left > right 
5 = bilateral right > left 
Metabol . 1 = hypomet. 2 = hypermet. 
Asym. 1 Absolute 1 = < 5% (none) 
Index 2 Index 2 = 5-10% (minimal) 
3 3 - 10-15% (mild) 
4 4 = 15-20% (moderate) 
5 5 = > 20% (severe) 
6 6 = post op (missing) 
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